OUR PIPELINE

Dragonfly's novel cytokines and "TriNKET" NK cell engagers can both kill cancers and other disease targets directly, and improve the outcomes of other immunotherapy approaches like T-cell therapies.

Our initial pipeline includes a range of disease targets from cancers to  

DISCOVERY

LEAD SELECTION

FILE IND

PHASE I

Dragonfly Solid Tumor Target DF1001

Dragonfly Heme Tumor Target DF2001

Dragonfly Heme Tumor Target DF3001

Dragonfly Heme Tumor Target DF4001

Dragonfly Heme Tumor Target DF5001

Dragonfly Cytokine DF6000